Comorbidities as Risk Factors for Acute and Recurrent Erysipelas
DOI:
https://doi.org/10.3889/oamjms.2019.214Keywords:
Erysipelas, Recurrent, Risk factor, LymphoedemaAbstract
BACKGROUND: Erysipelas is a common infectious skin disease. A typical feature of erysipelas, especially on the lower limbs, is the tendency to reoccur and the study aimed to define the comorbidities associated with it.
AIM: We aimed to investigate systemic and local comorbidities in patients diagnosed with erysipelas on the lower limbs.
MATERIAL AND METHODS: We conducted a retrospectively-prospective, population-based cohort study which included all patients diagnosed with erysipelas on the lower limbs, during two years. Patients were divided into two groups: patients with first episode and patients with recurrent erysipelas. These two groups were compared, with particular emphasis on systemic and local comorbidities.
RESULTS: The study included 313 patients, of which 187 with the first episode of erysipelas and 126 with a recurrent. Regarding the analyzed systemic risk factors, the recurrent erysipelas was significantly associated with obesity (p < 0.0001), insulin dependent diabetes mellitus (p = 0.0015), history of malignant disease (p = 0.02) and tonsillectomy (p = 0.000001). For a p-value < 0.0001, significantly more frequent finding of peripheral arterial occlusive disease, chronic oedema/lymphoedema, fungal infections of the affected leg and chronic ulcer was confirmed in recurrent erysipelas. Neuropathy had 23% of the recurrent cases and 8.6% in patients without recurrence, and the difference was found to be significant for p = 0.0003. The only dissection of the lymph nodes was found more frequently in recurrent erysipelas (p = 0.017), but no associations with other analysed local surgery on the affected leg. Patients with recurrent erysipelas had ipsilateral coexisting dermatitis p = 0.00003 significantly more frequent. Minor trauma often preceded the first episode of erysipelas p = 0.005.
CONCLUSION: Identification and treatment of modifiable risk factors are expected to reduce the risk of a subsequent episode of erysipelas on the lower limbs
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. New England Journal of Medicine. 1996; 334(4):240–6. https://doi.org/10.1056/NEJM199601253340407 PMid:8532002
Swartz M. Cellulitis. N Engl J Med. 2004; 350:904–12. https://doi.org/10.1056/NEJMcp031807 PMid:14985488
Raff AB, Kroshinsky D. Cellulitis: a review. JAMA. 2016; 316(3):325–37. https://doi.org/10.1001/jama.2016.8825 PMid:27434444
Dalal A, Eskinâ€Schwartz M, Mimouni D, Ray S, Days W, Hodak E, Leibovici L, Paul M. Interventions for the prevention of recurrent erysipelas and cellulitis. Cochrane Database of Systematic Reviews. 2017; 6:CD009758. https://doi.org/10.1002/14651858.CD009758.pub2
Blackberg A, Trell K, Rasmussen M. Erysipelas, a large retrospective study of aetiology and clinical presentation. BMC Infect Dis. 2015; 15:402. https://doi.org/10.1186/s12879-015-1134-2 PMid:26424182 PMCid:PMC4590694
Gunderson CG, Martinello RA. A systematic review of bacteremias in cellulitis and erysipelas. J Infect. 2012; 64:148-55. https://doi.org/10.1016/j.jinf.2011.11.004 PMid:22101078
Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol. 2006; 20:834e9.
Bartholomeeusen S, Vandenbroucke J, Truyers C, Buntinx F. Epidemiology and comorbidity of erysipelas in primary care. Dermatology. 2007; 215(2):118-22. https://doi.org/10.1159/000104262 PMid:17684373
Ellis Simonsen SM, Van Orman ER, Hatch BE, Jones SS, Gren LH, Hegmann KT, et al. Cellulitis incidence in a defined population. Epidemiology & Infection. 2006; 134(2):293–9. https://doi.org/10.1017/S095026880500484X PMid:16490133 PMCid:PMC2870381
Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014; 59:e10–52. https://doi.org/10.1093/cid/ciu296
Eriksson B, Jorup-Rönström C, Karkkonen K, Sjöblom AC, Holm SE. Erysipelas: clinical and bacteriologic spectrum and serological aspects. Clinical infectious diseases. 1996; 23(5):1091-8. https://doi.org/10.1093/clinids/23.5.1091 PMid:8922808
Dupuy A, Benchikhi H, Roujeau JC, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999; 318:1591–4. https://doi.org/10.1136/bmj.318.7198.1591 PMid:10364117 PMCid:PMC28138
Mcnamara DR, Tlyjeh IM, Berbari EF, Lahr BD, Martinez J, Mirzoyev SA, et al. A predictive model of recurrent lower extremity cellulitis in a population-based cohort. Arch Intern Med. 2007;167(7):709-15. https://doi.org/10.1001/archinte.167.7.709 PMid:17420430
Pavlotsky F, Amrani S, Trau H. Recurrent erysipelas: risk factors: Risikofaktoren für Rezidiverysipele. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2004; 2(2):89-95. https://doi.org/10.1046/j.1439-0353.2004.03028.x PMid:16279242
Karppelin M, Siljander T, Vuopio-Varkila J, Kere J, Huhtala H, Vuento R, Jussila T, Syrjanen J: Factors predisposing to acute and recurrent bacterial non-necrotizing cellulitis in hospitalized patients: a prospective case-control study. Clinical Microbiology & Infection. 2010; 16(6):729–34. https://doi.org/10.1111/j.1469-0691.2009.02906.x PMid:19694769
Cox NH. Oedema as a risk factor for multiple episodes of cellulitis/ erysipelas of the lower leg: a series with community follow-up. Br J Dermatol. 2006;155(5):947-50. https://doi.org/10.1111/j.1365-2133.2006.07419.x PMid:17034523
Lewis SD, Peter GS, Gomez-Marin O, Bisno AL. Risk factors for recurrent lower extremity cellulitis in a US Veterans Medical Center population. The American journal of the medical sciences. 2006; 332(6):304-7. https://doi.org/10.1097/00000441-200612000-00002 PMid:17170620
Karppelin M, Siljander T, Huhtala H, Aroma A, Vuopio J, Hannula-Jouppi K, et al. Recurrent cellulitis with benzathine penicillin prophylaxis associated with diabetes and psoriasis. European Journal of Clinical Microbiology& Infectious Diseases. 2013; 32(3):369–72. https://doi.org/10.1007/s10096-012-1751-2 PMid:23007460
Eron LJ, Lipsky BA, Low DE, Nathwani D, Tice AD, Volturo GA: Managing skin and soft tissue infections: expert panel recommendations on key decision points. J Antimicrob Chemother. 2003; 52(Suppl 1):i3–i17. https://doi.org/10.1093/jac/dkg466 PMid:14662806
Guidelines and Audit Implementation Network. CREST guidelines on the management of cellulitis in adults. Belfast, GAIN, June 2005.
British Lymphology Society (BLS). Consensus Document on the Management of Cellulitis in Lymphoedema. Revised Cellulitis Guidelines, 2016. www.lymphoedema.org/images/ pdf/CellulitisConsensus.pdf (accessed May 2017).
Societe Francaise de Dermatologie. Erysipelas and necrotizing fasciitis [Erysipele et fasiite necrosante: prise encharge]. Annales de dermatologie et de vénéréologie. 2001; 128:463–82. PMid:11319379
Mason JM, Thomas KS, Crook AM, Foster KA, Chalmers JR, Nunn AJ, et al. Prophylactic antibiotics to prevent cellulitis of the leg: economic analysis of the PATCH I & II trials. PLoS One. 2014; 9:e82694. https://doi.org/10.1371/journal.pone.0082694 PMid:24551029 PMCid:PMC3925077
Thomas KS, Crook AM, Nunn AJ, Foster KA, Mason JM, Chalmers JR, et al. Penicillin to prevent recurrent leg cellulitis. N Engl J Med. 2013; 368:1695e703.
Oh CC, Ko HC, Lee HY, et al. Antibiotic prophylaxis for preventing recurrent cellulitis: a systematic review and meta-analysis. J Infect. 2014; 69:26–34. https://doi.org/10.1016/j.jinf.2014.02.011 PMid:24576824
World Health Organization (WHO). Obesity: preventing and managing the global epidemic. WHO Technical Report Series, No. 894. Geneva: WHO, 2000.
National Intstitutes of Health. 10th Special report to the U.S. Congress on alcohol and health: highlights from current research from the Secretary of Health and Human Services, NIH publication no. 00-1583. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, 2000:429–30.
Moffatt CJ, Franks PJ, Doherty DC, Williams AF, Badger C, Jeffs E, Bosanquet N, Mortimer PS. Lymphoedema: an underestimated health problem. Qjm. 2003; 96(10):731-8. https://doi.org/10.1093/qjmed/hcg126 PMid:14500859
Jorup-Rönström C, Britton S. Recurrent erysipelas: predisposing factors and costs of prophylaxis. Infection. 1987; 15:105-6. https://doi.org/10.1007/BF01650206 PMid:3110071
Tay EY, Fook-Chong S, Oh CC, Thirumoorthy T, Pang SM, Lee HY. Cellulitis Recurrence Score: A tool for predicting recurrence of lower limb cellulitis. Journal of the American Academy of Dermatology. 2015; 72(1):140-5. https://doi.org/10.1016/j.jaad.2014.08.043 PMid:25443627
Harris RA, Hardman DT, Brown AR. CELLULITE AND THE OCCULT DIABETIC. Australian and New Zealand journal of surgery. 1996; 66(3):175-7. https://doi.org/10.1111/j.1445-2197.1996.tb01151.x PMid:8639138
Gibran NS, Jang YC, Isik FF, et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res. 2002; 108(1):122–8. https://doi.org/10.1006/jsre.2002.6525 PMid:12443724
Pozzilli P, Leslie RD. Infections and diabetes: mechanisms and prospects for prevention. Diabet Med. 1994; 11(10):935–41. https://doi.org/10.1111/j.1464-5491.1994.tb00250.x PMid:7895457
Delamaire M, Maugendre D, Moreno M, et al. Impaired leucocyte functions in diabetic patients. Diabet Med. 1997; 14(1):29–34. https://doi.org/10.1002/(SICI)1096-9136(199701)14:1<29::AID-DIA300>3.0.CO;2-V
Factor SH, Levine OS, Schwartz B, Harrison LH, Farley MM, McGeer A, Schuchat A. Invasive group A streptococcal disease: risk factors for adults. Emerging infectious diseases. 2003; 9(8):970-7. https://doi.org/10.3201/eid0908.020745 PMid:12967496 PMCid:PMC3020599
O'Neill AM, Thurston TL, Holden DW. Cytosolic Replication of Group A Streptococcus in Human Macrophages. MBio. 2016; 7:e00020-16. https://doi.org/10.1128/mBio.00020-16
Österlund A, Popa R, Nikkilä T, Scheynius A, Engstrand L. Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis. The Laryngoscope. 1997; 107(5):640-7. https://doi.org/10.1097/00005537-199705000-00016 PMid:9149167
Sendi P, Graber P, Johansson L, Norrby-Teglund A, Zimmerli W. Streptococcus agalactiae in relapsing cellulitis. Clinical infectious diseases. 2007; 44(8):1141-2. https://doi.org/10.1086/513034 PMid:17366471
Semel JD, Goldin H. Association of athlete's foot with cellulitis of the lower еxtremities: diagnostic value of bacterial cultures of ipsilateral interdigital space samples. Clin Infect Dis. 1996; 23(5):1162–4. https://doi.org/10.1093/clinids/23.5.1162
Baddour, LM and Bisno, AL (1984): Recurrent cellulitis after coronary bypass surgery. Association with superficial fungal infection in saphenous venectomy limbs. JAMA. 1984; 251(8):1049–52. https://doi.org/10.1001/jama.1984.03340320035023 PMid:6607365
Björnsdottir, S, Gottfredsson, M, Thorisdottir, AS, Gunnarsson, GB, Rikardsdottir, H, Kristjansson, M and Hilmarsdottir, I: Risk factors for acute cellulitis of the lower limb: a prospective case-control study. Clin Infect Dis. 2005; 41(10):1416-22. https://doi.org/10.1086/497127 PMid:16231251
Eriksson BK. Anal colonization of group G beta-hemolytic streptococci in relapsing erysipelas of the lower extremity. Clin Infect Dis. 1999; 29(5):1319–20. https://doi.org/10.1086/313467 PMid:10524984
Baddour LM, Bisno AL. Non-group A beta-hemolytic streptococcal cellulitis: association with venous and lymphatic compromise. Am J Med. 1985; 79(2):155-159. https://doi.org/10.1016/0002-9343(85)90003-8
Smith RD, Spittell JA, Schirger A. Secondary lymphedema of the leg: its characteristics and diagnostic implications. JAMA. 1963; 185:80–2. https://doi.org/10.1001/jama.1963.03060020040018 PMid:13989558
Dreyer G, Noroes J, Figueredo-Silva J, Piessens WF. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today. 2000; 16(12):544–8. https://doi.org/10.1016/S0169-4758(00)01778-6
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Vesna Brishkoska-Boshkovski, Irena Kondova-Topuzovska, Katerina Damevska, Andrej Petrov
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
